TP
THE PHAGE
Japan · AI
THE PHAGE develops personalized preventive-health services and AI models based on continuous glucose data.
Product
Its Glucose Flight service sits alongside development of CGFM, a foundation model trained on glucose time series. The research aims to capture individual metabolic patterns and support several tasks with one model, including forecasting glucose changes and assessing health risks.
The company is working with research institutions including Chiba University. Combining glucose traces with lifestyle information such as meals is part of its approach to more individualized analysis.
- Service
- Glucose Flight
- Research platform
- Continuous glucose foundation model
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A first close | ¥570M | ITOCHU Technology Ventures — LeadFukui Capital Partners — ParticipantGenesia Ventures — ParticipantShoko Chukin Bank — ParticipantTokio Marine & Nichido Fire Insurance — ParticipantVision Incubate Co — Participant |